Sign in

Versiti Blood Research Institute

@versitiresearch.bsky.social
151 followers 25 following 80 posts

The VBRI is dedicated to hematology in all its facets, spanning basic, translational and clinical research, all with one goal: to make people’s lives better. versiti.org/versiti-blood-research-…

PostsRepliesMedia
Versiti Blood Research Institute @versitiresearch.bsky.social · 06/08/2025
Quick peek at the 2nd deck concrete pour of the VBRI expansion! From groundbreaking 11 months ago to this milestone! We're building the future of blood health research day by day. #PublicHealth #BloodHealth
020
Versiti Blood Research Institute @versitiresearch.bsky.social · 04/08/2025
The Kastrup Lab @ VBRI recently published a technique that may prevent dangerous blood clots after trauma without stopping normal healing. The targeted siRNA therapy keeps clotting proteins in the safe zone in the murine model. Learn more: journals.lww.com/jtrauma/abst...
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 22/07/2025
We're proud to stand with our colleagues at @ash.hematology.org and the #Fight4Hematology campaign. Supporting emerging researchers and innovative care approaches strengthens our entire field's capacity to transform lives. Learn more and get involved: www.hematology.org/advocacy/fig...
hematology.org
Fight4Hematology - Hematology.org
Fight4Hematology
021
Reposted by Versiti Blood Research Institute
Joshua Muia @joshuamuia.bsky.social · 21/06/2025
Congratulations to Bob Montgomery @versitiresearch.bsky.social for the being the recipient of the 2025 Harold R. Roberts Award @isth.org #ISTH2025
084
Reposted by Versiti Blood Research Institute
International Society on Thrombosis and Haemostasis @isth.org · 13/06/2025
🥳The ISTH proudly presents the Harold R. Roberts Award to Dr. Robert R. Montgomery in recognition of his enduring contributions. His decades of leadership through the ISTH SSC and @versitiresearch.bsky.social reflect a career shaped by curiosity, perseverance & impact. Read more: bit.ly/3FO1cVe
063
Versiti Blood Research Institute @versitiresearch.bsky.social · 28/04/2025
PF4-dependent P-selectin expression assay in comparison to the heparin-induced platelet activation assay for the diagnosis of heparin-induced thrombocytopenia pubmed.ncbi.nlm.nih.gov/40191970/
pubmed.ncbi.nlm.nih.gov
PF4-dependent P-selectin expression assay in comparison to the heparin-induced platelet activation assay for the diagnosis of heparin-induced thrombocytopenia - PubMed
These findings suggest that the PEA is a promising functional test for HIT laboratory diagnostics based on the relatively high sensitivity; however, further studies are needed to validate its clinical...
100
Versiti Blood Research Institute @versitiresearch.bsky.social · 28/04/2025
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression: pubmed.ncbi.nlm.nih.gov/40196236/
pubmed.ncbi.nlm.nih.gov
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression - PubMed
The use of sNK cells in immunotherapy emerges as a potentially effective strategy to target and eliminate the majority of ovarian tumour clones, thereby providing a potential therapeutic opportunity i...
100
Versiti Blood Research Institute @versitiresearch.bsky.social · 24/04/2025
Great work and great collaboration! #TeamScience Learn more about Dr. Alan Mast and the Thrombosis and Hemostasis Lab at Versiti: versiti.org/versiti-bloo...
versiti.org
Versiti - Alan E. Mast, MD, PhD | Versiti Blood Research Institute
Dr. Mast is the Walter Schroeder Endowed Chair for Blood Research and a senior investigator at Versiti Blood Research Institute.
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 08/04/2025
Join us on Wed. 4/23 as we showcase the groundbreaking work of women in science at the VBRI! All ages are welcome as we profile the impactful innovation coming from @versiti.bsky.social and inspire future researchers. Register for free: versiti.org/ways-to-give... #WeResearchCures
You're Invited: Women Rocking Research
April 23 at the Versiti Blood Research Institute
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 04/03/2025
At Versiti Perspective: Sickle Cell Disease, experts, advocates and community members joined to advance awareness and research. Guests heard from Chris Miskel, Prithu Sundd, Ph.D., and more, toured VBRI and learned their blood type. Give blood, save lives: bitly.versiti.org/3DaSHlw.
012
Versiti Blood Research Institute @versitiresearch.bsky.social · 14/02/2025
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators pubmed.ncbi.nlm.nih.gov/39643951/
pubmed.ncbi.nlm.nih.gov
Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab - PubMed
In multiple sclerosis (MS) the B cell depleting drug ocrelizumab has shown high efficacy in reducing inflammatory activity. Its mechanism of action is unclear due to B cell subset complexity and unkno...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 14/02/2025
Check out publication by VBRI Senior Investigator and Program Co-Leader Alan Mast and collaborators pubmed.ncbi.nlm.nih.gov/39652409/
pubmed.ncbi.nlm.nih.gov
The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative - PubMed
Clinical trial design for classical hematologic diseases is difficult because samples sizes are often small and not representative of the disease population. The American Society of Hematology initiat...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 14/02/2025
Check out publication by VBRI Senior Medical Director, Investigator Lisa Baumann Kreuziger and collaborators pubmed.ncbi.nlm.nih.gov/39930618/
pubmed.ncbi.nlm.nih.gov
Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis - PubMed
Guidelines for diagnosing pulmonary embolism (PE) start with a risk assessment using a pretest probability (PTP) tool, followed by D-dimer testing or computed tomography pulmonary angiography (CTPA) d...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 14/02/2025
Check out publication by VBRI Associate investigator Dipa Pradhan-Sundd and collaborators pubmed.ncbi.nlm.nih.gov/39936985/
pubmed.ncbi.nlm.nih.gov
Heme-Oxygenase 1 Mediated Activation of Cyp3A11 Protects Against Non-Steroidal Pain Analgesics Induced Acute Liver Damage in Sickle Cell Disease Mice - PubMed
Pain constitutes a significant comorbidity associated with sickle cell disease (SCD). Analgesics serve as the primary method for pain management; however, the long-term effects of these drugs on the l...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 14/02/2025
Check out publication by VBRI Associate investigator Yiliang Chen and collaborators pubmed.ncbi.nlm.nih.gov/39943809/
pubmed.ncbi.nlm.nih.gov
Angiotensin 1-7 and a TERT activator individually restore vasodilatory capacity within the microcirculation previous SARS-CoV-2 infection - PubMed
Angiotensin 1-7 and a TERT activator individually restore vasodilatory capacity within the microcirculation previous SARS-CoV-2 infection
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 14/02/2025
Check out publication by VBRI Associate investigator Joshua Muia and collaborators pubmed.ncbi.nlm.nih.gov/39945068/
pubmed.ncbi.nlm.nih.gov
Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity - PubMed
These results demonstrate the crucial role of arginine methylation on ADAMTS13 secretion and activity. Our findings may shed new light on the mechanism of allosteric regulation of ADAMTS13, which may ...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 07/02/2025
Check out publication by VBRI Senior Investigator Emeritus Thomas Abshire and collaborators pubmed.ncbi.nlm.nih.gov/39461724/
pubmed.ncbi.nlm.nih.gov
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years - PubMed
These findings support durability of the Kids-DOTT randomized clinical trial findings of net clinical benefit at 2 years.
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 07/02/2025
Check out publication by VBRI Senior Investigator and Program Co-Leader Alan Mast and collaborators pubmed.ncbi.nlm.nih.gov/39536817/
pubmed.ncbi.nlm.nih.gov
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach - PubMed
The effectiveness of concizumab is mediated through the blockade of TFPI anticoagulant activities in plasma and on multiple physiological surfaces. An important and previously unrecognized function of...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 07/02/2025
Check out publication by VBRI Senior investigator Jieqing Zhu and collaborators in pubmed.ncbi.nlm.nih.gov/39906208/
pubmed.ncbi.nlm.nih.gov
Borrelia burgdorferi tolerates alteration to P66 porin function in a murine infectivity model - PubMed
<span><i>Borrelia burgdorferi</i> exists in a complex enzootic life cycle requiring differential gene regulation. P66, a porin and adhesin, is upregulated and essential during mammalian infection, but...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 07/02/2025
Check out publication by VBRI Senior Medical Director, Investigator Lisa Baumann-Kreuziger and collaborators in pubmed.ncbi.nlm.nih.seniorgov/39911106/
pubmed.ncbi.nlm.nih.gov
Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation - PubMed
Not available.
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 31/01/2025
Angela Beltrame spoke with students about her work, her journey and how she came to collaborate with the VBRI.
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 31/01/2025
Dr. Alexis Smith spoke with students about her interest in science and her journey.
120
Versiti Blood Research Institute @versitiresearch.bsky.social · 31/01/2025
Communications Committee Presents: High School Students Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. Jayson Bartlein came to speak with the students about his role at the VBRI.
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 31/01/2025
Communications Committee Presents: High School Students Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. We had Dawn Wenzel come share information regarding programs at MCW.
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 31/01/2025
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators in pubmed.ncbi.nlm.nih.gov/39879070/
pubmed.ncbi.nlm.nih.gov
What's on the horizon? - PubMed
What's on the horizon?
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 24/01/2025
Check out publication by VBRI Senior Medical Director, Investigator Lisa Baumann Kreuziger and collaborators in pubmed.ncbi.nlm.nih.gov/39626301/
pubmed.ncbi.nlm.nih.gov
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era - PubMed
Immune thrombotic thrombocytopenic purpura (iTTP) is a chronically relapsing disorder caused by autoantibody-mediated deficiency of ADAMTS13. Rituximab is frequently administered to prevent relapses, ...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 24/01/2025
Check out publication by VBRI EVP Medical Sciences Institute and Chief Medical Officer Matthew Anderson and collaborators in pubmed.ncbi.nlm.nih.gov/39642776/
pubmed.ncbi.nlm.nih.gov
High rates of MHC mismatches in HLA matched unrelated donor/recipient pairs and potential impact on hematopoietic cell transplant outcome - PubMed
NCML mismatching is present in HLA-matched unrelated HCT donor and recipient pairs and may contribute to outcomes in unrelated HLA-matched HCT.
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 24/01/2025
Check out publication by VBRI Senior Investigator and Program Co-Leader Qizhen Shi and collaborators in pubmed.ncbi.nlm.nih.gov/39842018/
pubmed.ncbi.nlm.nih.gov
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History - PubMed
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday party 1.16.25
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday Party 1.16.25 Look who came to party!!!!
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday party 1.16.25 Bingo!!!!
020
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday Party 1.16.25 Bingo!!!!
020
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday Party 1.16.25 Bingo!!!!
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday party 1.16.25 Bingo!!!!!
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday Party 1.16.25 Goodies spread 🙂
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday Party 1.16.25 White Elephant!!!
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday Party 1.16.25 White Elephant!!!
020
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Holiday Party 1.16.25 White Elephant!!!!
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/01/2025
Check out publication by VBRI Senior Investigator and Program Co-Leader Christian Kastrup and collaborators in pubmed.ncbi.nlm.nih.gov/39341369/
pubmed.ncbi.nlm.nih.gov
Genetic engineering of megakaryocytes from blood progenitor cells using messenger RNA lipid nanoparticles - PubMed
This approach provides an easy-to-use modular platform to genetically modify MK and MK progenitors, which can be potentially extended to producing genetically modified cultured platelets.
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 13/01/2025
Check out publication by VBRI Research Scientist II Tomasz Kaminski and collaborators in pubmed.ncbi.nlm.nih.gov/39769454/
pubmed.ncbi.nlm.nih.gov
The Complex Role of Matrix Metalloproteinase-2 (MMP-2) in Health and Disease - PubMed
Matrix metalloproteinase-2 (MMP-2), a zinc-dependent enzyme, plays a critical role in the degradation and remodeling of the extracellular matrix (ECM). As a member of the gelatinase subgroup of matrix...
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 13/01/2025
Check out publication by VBRI Associate investigator Joshua Muia and collaborators in pubmed.ncbi.nlm.nih.gov/39787593/
pubmed.ncbi.nlm.nih.gov
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke - PubMed
Respiratory tract infections (RTIs) caused by bacteria or viruses are associated with stroke severity. Recent studies have revealed an imbalance in the von Willebrand factor (VWF)-ADAMTS13 axis in pat...
110
Versiti Blood Research Institute @versitiresearch.bsky.social · 03/01/2025
Check out publication by VBRI EVP and Chief Scientific Officer, Senior Investigator and Director Michael Deininger and collaborators in pubmed.ncbi.nlm.nih.gov/39729529/
pubmed.ncbi.nlm.nih.gov
Novel Treatment Strategies for Chronic Myeloid Leukemia - PubMed
Starting with imatinib, tyrosine kinase inhibitors (TKIs) have turned chronic myeloid leukemia (CML) from a lethal blood cancer into a chronic condition. As patients with access to advanced CML care h...
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 03/01/2025
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators in pubmed.ncbi.nlm.nih.gov/39731832/
pubmed.ncbi.nlm.nih.gov
Corrigendum to "Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels are B cell depletion with Ocrelizumab" [J. Neuroimmunol. 339:578502 (2024)] -...
Corrigendum to "Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels are B cell depletion with Ocrelizumab" [J. Neuroimmunol. 339:578502 (2024)]
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 31/12/2024
Great moments! Year 2024
010
Versiti Blood Research Institute @versitiresearch.bsky.social · 27/12/2024
Check out publication by VBRI Investigator and Program Leader Sid Rao and collaborators in pubmed.ncbi.nlm.nih.gov/39723540/
pubmed.ncbi.nlm.nih.gov
Chromatin State Maps of Blood Pressure-Relevant Renal Segments Reveal Potential Regulatory Role for SNPs - PubMed
Collectively, this study lays a foundation for interrogating how intergenic single nucleotide polymorphisms may regulate polygenic traits such as BP.
120
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/12/2024
Check out publication by VBRI Senior investigator Renren Wen and collaborators in pubmed.ncbi.nlm.nih.gov/39091061/
pubmed.ncbi.nlm.nih.gov
Deep phosphotyrosine characterisation of primary murine T cells using broad spectrum optimisation of selective triggering - PubMed
Sequencing the tyrosine phosphoproteome using MS-based proteomics is challenging due to the low abundance of tyrosine phosphorylation in cells, a challenge compounded in scarce samples like primary ce...
120
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/12/2024
Check out publication by VBRI Senior Research Scientist Nataly Cruz-Rodriguez in Deininger's lab and collaborators in pubmed.ncbi.nlm.nih.gov/39676870/
pubmed.ncbi.nlm.nih.gov
ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemia - PubMed
These findings highlight significant differences in ID1 and ID3 expression levels and their impact on TIME populations, particularly neutrophil-related pathways. The results suggest a potential role f...
120
Versiti Blood Research Institute @versitiresearch.bsky.social · 20/12/2024
Congrats to Melissa Manley, Myesha Ferguson and Melody Reichoff on receiving their yellow belt for non-employee onboarding. Great job!
020
Versiti Blood Research Institute @versitiresearch.bsky.social · 18/12/2024
Check out publication by VBRI Senior investigator Peter Newman and collaborators in pubmed.ncbi.nlm.nih.gov/39520801/
pubmed.ncbi.nlm.nih.gov
Antigen-specific immunotherapy for platelet alloimmune disorders - PubMed
Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT) is a significant hematologic disorder arising from maternal immune responses to fetal platelet alloantigens, predominantly Human Platelet Antigen (HP...
140
Versiti Blood Research Institute @versitiresearch.bsky.social · 18/12/2024
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators in pubmed.ncbi.nlm.nih.gov/39643951/
pubmed.ncbi.nlm.nih.gov
Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab - PubMed
In multiple sclerosis (MS) the B cell depleting drug ocrelizumab has shown high efficacy in reducing inflammatory activity. Its mechanism of action is unclear due to B cell subset complexity and unkno...
120